5-Amino-1MQ: research, legal status and who sells it
This page is information, not medical advice. 5-Amino-1MQ is not approved as a medicine in the markets below unless stated. We don't publish dosing or usage instructions.
- Also known as
- 5-Amino-1-methylquinolinium
- Category
- Small-molecule inhibitor of the enzyme NNMT (not a peptide)
- Evidence level
- Preclinical (lab and animal studies)
- Price range
- $0.750/mg to $10.00/mg, median $2.90/mg across 57 vendors (compare)
- Our lab tests
- None yet (how testing will work)
Legal and regulatory status
| Where | Status |
|---|---|
| United States | No FDA-approved drug contains 5-amino-1MQ [1]. |
| United Kingdom | No UK-licensed medicine containing 5-amino-1MQ appears in the MHRA products database [2]. |
| European Union | No medicine containing 5-amino-1MQ is authorized in the EU, according to EMA's central and Article 57 product data [3][4]. |
| Canada | No product containing 5-amino-1MQ appears in Health Canada's Drug Product Database [5]. |
| Australia | 5-amino-1MQ is not named in Australia's Poisons Standard (October 2026) [6]. |
| Sport (WADA) | Not named on the 2026 Prohibited List; its section S0 bans any pharmacological substance with no current approval for human therapeutic use [7]. |
We haven't published a full overview of 5-Amino-1MQ yet. The legal status table and live prices on this page are current.
5-Amino-1MQ prices: cheapest listings
The five lowest $/mg listings out of 95. See all 5-Amino-1MQ prices
| Vendor | Transparency | Product | Size | Price | $/mg | Stock | Vendor's page |
|---|---|---|---|---|---|---|---|
| Bulk Peptide Supply | 57 | 50 mg × 10 | $375 | $0.750/mg | View | ||
| Peptides World | 80 | 100 mg | $79 | $0.790/mg | View | ||
| Eros Peptides | 87 | 50 mg | $42 | $0.850/mg | View | ||
| Crush Research | 10 | 50 mg × 5 | $219 | $0.876/mg | Out of stock | View | |
| Crush Research | 10 | 50 mg × 3 | $139 | $0.927/mg | Out of stock | View |
Sources
- Drugs@FDA: FDA-Approved Drugs (database searched by active ingredient). U.S. Food and Drug Administration. Accessed Oct 15, 2026
- MHRA Products: licensed-medicine search for "5-amino-1mq". Medicines and Healthcare products Regulatory Agency (UK). Accessed Oct 15, 2026
- EMA medicines data: centrally authorised human medicines (export of 14 October 2026). European Medicines Agency. Accessed Oct 15, 2026
- EMA Article 57 product data: medicines authorised in the EU/EEA (data as of 9 October 2026). European Medicines Agency. Accessed Oct 15, 2026
- Drug Product Database online query (searched by active ingredient). Health Canada. Accessed Oct 15, 2026
- Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026 (F2026L01327, registered 30 September 2026). Federal Register of Legislation, Australian Government. Accessed Oct 15, 2026
- World Anti-Doping Code International Standard: Prohibited List 2026 (in force 1 January 2026). World Anti-Doping Agency. Accessed Oct 15, 2026
- Roles of Nicotinamide N-Methyltransferase in Obesity and Type 2 Diabetes. BioMed Research International (2021). Accessed Oct 15, 2026
- Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. Biochemical Pharmacology (2018). Accessed Oct 15, 2026